|
| Analyst
Scorecard | | Analyst: | Birchenough, Jim | EPS
Est. Accuracy: | Not Avl.
| | Broker: | Barclays Capital | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
| Not Avl.
| Not Avl.
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
AMGN
|
Amgen Inc
|
|
21
| | | | |
AMLN
|
Amylin Pharmaceuticals Inc
|
|
15
| | | | |
ARIA
|
Ariad Pharmaceuticals Inc
|
|
9
| | | | |
ARNA
|
Arena Pharmaceuticals Inc
|
|
12
| | | | |
ARRY
|
Array Biopharma Inc
|
|
11
| | | | |
BIIB
|
Biogen Idec Incorporated
|
|
21
| | | | |
CELG
|
Celgene Corporation
|
|
23
| | | | |
CEPH
|
Cephalon Inc
|
|
22
| | | | |
CRME
|
Cardiome Pharma Corp
|
|
4
| | | | |
GENZ
|
Genzyme Corp
| 
|
21
| | | | |
GHDX
|
Genomic Health Inc
|
|
8
| | | | |
HGSI
|
Human Genome Sciences Incorporat
|
|
11
| | | | |
ISIS
|
Isis Pharmaceuticals Inc
|
|
13
| | | | |
NPSP
|
Nps Pharmaceuticals
|
|
6
| | | | |
ONXX
|
Onyx Pharmaceuticals Inc
|
|
13
| | | | |
OSIP
|
Osi Pharmaceuticals Inc
|
|
15
| | | | |
REGN
|
Regeneron Pharmaceuticals
|
|
11
| | | | |
RIGL
|
Rigel Pharmaceuticals
|
|
11
| | | | |
SNTA
|
Synta Pharmaceuticals Corp
|
|
5
| | | | |
THRX
|
Theravance Inc
|
|
10
| | | | |
ZGEN
|
Zymogenetics Inc.
|
|
5
| | | |
| Other Stocks Covered
| |
Gilead Sciences Inc (GILD), United Therapeutics Corporation (UTHR)
|
| | |
|
|
|